our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 9 August 2016

    Antares Pharma Reports Second Quarter 2016 Operating And Financial Results
  • 2 August 2016

    Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and Conference Call
  • 27 June 2016

    TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States
  • 23 June 2016

    Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product
  • 1 June 2016

    Antares Pharma Announces Update to Quickshot Testosterone Program
  • 24 May 2016

    Antares Pharma will be attending the BIO International Convention June 6-9 in San Francisco. We look forward to meeting with you at our exhibition booth #5778!

latest products & technology


Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>